A new trading day began on Monday, with Niagen Bioscience Inc (NASDAQ: NAGE) stock price up 3.74% from the previous day of trading, before settling in for the closing price of $13.63. NAGE’s price has ranged from $2.31 to $14.49 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 16.56% over the past five years. Meanwhile, its annual earnings per share averaged 25.10%. With a float of $49.81 million, this company’s outstanding shares have now reached $78.43 million.
Let’s look at the performance matrix of the company that is accounted for 104 employees. In terms of profitability, gross margin is 62.51%, operating margin of 12.26%, and the pretax margin is 13.51%.
Niagen Bioscience Inc (NAGE) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Niagen Bioscience Inc is 36.77%, while institutional ownership is 31.88%. The most recent insider transaction that took place on Mar 07 ’25, was worth 2,146. In this transaction SVP, General Counsel of this company bought 273 shares at a rate of $7.86, taking the stock ownership to the 2,251 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Director sold 37,161 for $6.19, making the entire transaction worth $229,956. This insider now owns 244,179 shares in total.
Niagen Bioscience Inc (NAGE) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 25.10% per share during the next fiscal year.
Niagen Bioscience Inc (NASDAQ: NAGE) Trading Performance Indicators
Here are Niagen Bioscience Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.32. Likewise, its price to free cash flow for the trailing twelve months is 57.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.17, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.24 in one year’s time.
Technical Analysis of Niagen Bioscience Inc (NAGE)
Niagen Bioscience Inc (NASDAQ: NAGE) saw its 5-day average volume 0.92 million, a positive change from its year-to-date volume of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 84.12%. Additionally, its Average True Range was 0.65.
During the past 100 days, Niagen Bioscience Inc’s (NAGE) raw stochastic average was set at 96.21%, which indicates a significant increase from 91.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.54% in the past 14 days, which was lower than the 90.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.34, while its 200-day Moving Average is $6.48. Nevertheless, the first resistance level for the watch stands at $14.46 in the near term. At $14.78, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.10. If the price goes on to break the first support level at $13.81, it is likely to go to the next support level at $13.48. The third support level lies at $13.16 if the price breaches the second support level.
Niagen Bioscience Inc (NASDAQ: NAGE) Key Stats
With a market capitalization of 1.11 billion, the company has a total of 78,770K Shares Outstanding. Currently, annual sales are 99,600 K while annual income is 8,550 K. The company’s previous quarter sales were 30,480 K while its latest quarter income was 5,060 K.
